Equity

Ares Management Corporation (NYSE:ARES) HOLD

2026-07-16Current US$125.43Short HOLD · Med BUY · Long BUYBear US$95Base US$150Bull US$170

A hold on the near-term tape, a buy for the medium and long term. Ares is a high-quality, fee-centric alternative asset manager trading at an attractive multiple on distributable earnings after a 36% de-rate, but the short-term chart is recovering and unconfirmed — below the 200-day line, no volume breakout. Medium and long term are both BUY on the quality and valuation; accumulate on weakness rather than chase here.

Ares Management runs roughly 644 billion US dollars across private credit, private equity and real estate. It is a toll-booth on private capital: it clips a recurring management fee on other people's money, and it is a first-mover incumbent in direct lending, the fastest-growing corner of the industry. The report re-presents the 16 July 2026 signal at 125.43 US dollars a share.

Quality — a fee-centric compounder

The business quality is high, scored 78. Fee-related earnings grew 26 percent year on year at a 42 percent margin that is still expanding, and total assets under management reached 644 billion US dollars. What sets Ares apart is that it leans on recurring management fees rather than volatile performance fees, so its earnings are steadier than most large peers. Fundraising is best-in-class — a record 30 billion US dollars in a single quarter. Competition is real and intensifying from Blackstone, Apollo and Blue Owl, so the moat is durable but not immune. That is a quality tell, and it underwrites the medium and long BUY.

Quality — a fee-centric compounder
Quality — a fee-centric compounder — Donatien Investment

Valuation — attractive after a 36% de-rate

Valuation is attractive, scored 70. The important trap here is that the reported GAAP price-to-earnings of about 55 times is distorted by consolidated-fund accounting and is a poor guide. On the correct alt-manager lens — price to distributable earnings — Ares trades at 25.5 times trailing and 21 times forward, against a warranted multiple of 28.3 times. That is a ratio of 0.90, firmly in the attractive band, and the 36 percent drop from the 195 dollar high did the de-rating. The price embeds only low-teens durable growth, below Ares' recent 20-percent-plus trajectory. It does not require heroic assumptions.

Valuation — attractive after a 36% de-rate
Valuation — attractive after a 36% de-rate — Donatien Investment

Timing — recovering but unconfirmed

Timing is the weak pillar, scored 46, and it is why the short-term signal is a HOLD, not a BUY. Ares is bouncing off a deep pullback and has reclaimed its 20 and 50-day moving averages, but it still sits below the 200-day line at about 136, and the weekly trend is still down. The bounce is not backed by volume, so there is no confirmed breakout. On top of that, a Fed decision, a growth-and-inflation print and Ares' own earnings all cluster into the same week at the end of July — a genuinely binary window. The report says buy on confirmation: a volume reclaim of 136, or a tested higher low off the 118 to 120 support zone.

Timing — recovering but unconfirmed
Timing — recovering but unconfirmed — Donatien Investment

What could go wrong

20% bear case: private-credit stress tail is live. A default cascade would hit AUM, marks and fundraising. Bear target 95 — a revisit of the 2026 low. Stop below 116; earnings 31 Jul can reset the clock.

What could go wrong — Donatien Investment
What could go wrong — Donatien Investment

Risk vs Reward

Bear
US$95
Base
US$150
Bull
US$170

Against the current US$125.43, the report frames a bull case at US$170 (+36%), a base case at US$150 (+20%) and a bear case at US$95 (-24%). See the full report for the probability weight behind each path.

The verdict

Short HOLDMedium BUYLong BUY

A hold on the near-term tape, a buy for the medium and long term. Ares is a high-quality, fee-centric alternative asset manager trading at an attractive multiple on distributable earnings after a 36% de-rate, but the short-term chart is recovering and unconfirmed — below the 200-day line, no volume breakout. Medium and long term are both BUY on the quality and valuation; accumulate on weakness rather than chase here.

⬇ Infographic (X / Twitter)⬇ Infographic (Instagram)
Read the full report on donatien.ca →